GESTIÓN EN SALUD PÚBLICA: Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) in a Healthcare Setting

sábado, 1 de febrero de 2020

Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) in a Healthcare Setting | NLM

Disaster Information Management Research Center | NLM

Disaster Information and Emergency Response

Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) in a Healthcare Setting

01/28/2020 12:00 AM EST

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 1/28/2020. This guidance, updated on January 28, 2020, is based on the currently limited information available about 2019-nCoV related to disease severity, transmission efficiency, and shedding duration. This cautious approach will be refined and updated as more information becomes available and as response needs change in the United States. This guidance is applicable to all U.S. healthcare settings. This guidance is not intended for non-healthcare settings (e.g., schools) or to persons outside of healthcare settings. (Text)